The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1308 articles
Eli Lilly's experimental drug retatrutide is showing unprecedented weight loss results, pushing the boundaries of what's possible. But with great power comes great responsibility, and doctors are urging caution.
A major bust at a country estate near Northampton has led to the seizure of 12,000 doses of illicit weight loss medications, including potent peptide drugs. Two men have been arrested as the Medicines and Healthcare products Regulatory Agency (MHRA) cracks down on dangerous counterfeit and unlicensed medicines.
GLP-1 receptor agonists, initially celebrated for revolutionizing diabetes and weight management, are now at the center of an unplanned, massive neuroscience experiment. Emerging data suggests these powerful medications are doing more than just regulating metabolism; they appear to be structurally and functionally altering key brain systems.
The rapid adoption of GLP-1 agonists like Ozempic and Wegovy is forcing a profound realignment in the food and beverage industry. Initial hopes that users would eventually return to old habits have faded, replaced by a strategic pivot toward 'companion nutrition' tailored to the specific, evolving needs of individuals managing weight and metabolic health.
New-generation GLP-1 drugs like retatrutide promise unprecedented weight loss, but what are the implications for your body's composition and overall health? This article delves into the science, risks, and strategies for navigating rapid weight reduction.
GHK-Cu peptide is gaining significant attention for its potential in skin rejuvenation and anti-aging. This article delves into what GHK-Cu is, why it's popular, and the crucial role of medical oversight in its application, moving beyond online trends to evidence-based practice.
Peptides, the signaling molecules built from amino acids, are emerging as precise tools for targeted wellness, especially as the body's natural production declines after 50. Learn which five peptides can help restore vitality, repair tissue, and combat aging-related inflammation.
Discover how new studies are reshaping our understanding of Type 2 diabetes management with tirzepatide and offering critical insights into the biological drivers of Long COVID's persistent neurological symptoms.
South Africa's regulatory bodies are taking decisive action against the booming market for compounded GLP-1 weight-loss drugs, including versions of Ozempic and Mounjaro. This crackdown highlights significant safety concerns and potential risks to public health.
